Neumayer Matthew Paul 4
4 · OSIRIS THERAPEUTICS, INC. · Filed Feb 16, 2011
Insider Transaction Report
Form 4
Neumayer Matthew Paul
Principal Accounting Officer
Transactions
- Award
Incentive Stock Option (right to buy)
2011-02-14$7.13/sh+4,000$28,520→ 14,000 totalExercise: $7.13From: 2012-02-14Exp: 2021-02-14→ Common Stock (4,000 underlying)
Footnotes (1)
- [F1]The option to purchase 4,000 shares of the common stock of Osiris Therapeutics, Inc. shall become exercisable with respect to the underlying shares as to 25% on each of February 14, 2012, 2013, 2014 and 2015, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.